This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Frueh FW, Gurwitz D . From pharmacogenetics to personalized medicine: a vital need for educating health professionals and the community. Pharmacogenomics 2004; 5: 571–579.
Workshop on Pharmacogenetics/Pharmacogenomics in Drug Development and Regulatory Decision-Making. 5/16–17/2002, Sponsored by FDA, PhRMA DruSafe and PWG, Rockville, MD.
FDA/DIA/PhRMA/PWG/Bio Workshop on Pharmacogenomics in Drug Development and Regulatory Decision-Making: The Genomic Data Submission (GDS) Proposal, 11/13–14/2003, Washington, DC.
FDA/DIA Pharmacogenomics Workshop: Co-Development of Drug, Biological, and Device Products, 7/29/2004, Arlington, VA.
Pharmacogenomics in Drug Development and Regulatory Decision Making—Workshop 3: Three Years of Promise, Proposals, and Progress on Optimizing the Benefit/Risk of Medicines, Co-sponsored by IA, FDA, PWG, PhRMA & BIO, 4/11-13/2005, Bethesda, MD.
Lesko LJ, Woodcock J . Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective. Nat Rev Drug Discov 2004; 3: 763–769.
Lesko LJ, Woodcock J . Pharmacogenomic-guided drug development: regulatory perspective. Pharmacogenom J 2002; 2:20–24.
http://www.fda.gov/cder/biologics/products/trasgen092598.htm.
http://www.fda.gov/cder/foi/label/2002/21411_strattera_lbl.pdf.
http://www.fda.gov/ohrms/dockets/ac/04/briefing/2004-4079b1.htm.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Frueh, F., Goodsaid, F., Rudman, A. et al. The need for education in pharmacogenomics: a regulatory perspective. Pharmacogenomics J 5, 218–220 (2005). https://doi.org/10.1038/sj.tpj.6500316
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.tpj.6500316
This article is cited by
-
Pharmacogenetics and ethical considerations: why care?
The Pharmacogenomics Journal (2007)